Camiel Göbel

In 2020, I obtained my master's degree in Biomolecular Sciences from the VU. In line with the master programme, I joined the Schoenberger group at the La Jolla Institute for Immunology in San Diego, where I conducted research regarding the identification of neoantigen-specific T cells in ovarian cancer.

Following my graduation, I joined the group of Heinz Jacobs as PhD student. Here, in collaboration with the group of Fred van Leeuwen, my main focus is to establish epigenetic-based therapies to improve treatment of diffuse large B-cell lymphoma (DLBCL).